Effectiveness of 12-octadecenoic acid methyl ester, an active ingredientin Kansui, in inhibiting non-small cell lung carcinoma cells potential
DOI:
https://doi.org/10.61173/29efva17Keywords:
12-octadecenoic acid methyl ester, Non-small cell lung cancer (NSCLC), Autophagy, LC3-BAbstract
Lung cancer is widespread in China and has many new cases and deaths. There are about 450000 new cancer patients
in China every year. Non-small cell lung cancer (NSCLC) accounted for 80%. Previous studies have found that T33,
a TCM formula, has the function of treating cancer by inducing autophagy of Colorectal cancer. Therefore, his study
aims to determine the ability of 12-octadecenoic acid methyl ester (an active ingredient in T33) to induce autophagy
of A549 non-small cell lung cancer to expand the available treatment methods for lung cancer patients. This study will
measure cell killing by MTT in vitro and tumor size reduction of A549 xenografts in vivo and measure autophagy by
LC3-A/B western blot. The positive control is taxol, and negative control is PBS/DMSO. In this study, by observing
the size of cancer cell tissue and the number of LC3-A/B, we can determine whether 12-octadecenoic acid methyl ester
can successfully induce autophagy of NSCLC and thus generate the potential for the treatment of NSCLC. The results
of this study will provide some potential theoretical basis for the principle of traditional Chinese medicine in treating
cancer.
References
[1] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
[2] Globocan. International agency for research of cancer. <http://globocan.iarc.fr/>; 2020.
[3] Doll R, Peto R. Mortality in relation to smoking: 20 years’ observations on male British doctors. Brit Med J 1976;2:1525– 36.
[4] Xue, C., Hu, Z., Jiang, W., Zhao, Y., Xu, F., Huang, Y., … Zhang, L. (2012). National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China.Lung Cancer, 77(2), 371–375.
[5] Lorin, S.; Hamai, A.; Mehrpour, M.; Codogno, P. Autophagy regulation and its role in cancer. Semin. Cancer Biol. 2013, 23, 361–379. [CrossRef] [PubMed]
[6] White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12, 401–410. [CrossRef] [PubMed]
[7] Yu-Te Liu, Chao-Hsiang Hsiao, Bor-Show Tzang and Tsai- Ching Hsu.(2019) In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells. 19:211
[8] <https://www.caymanchem.com/product/10010180/cis-12- octadecenoic-acid-methyl-ester>
[9] Oie, H. K., Russell, E. K., Carney, D. N., & Gazdar, A. F. (1996). Cell culture methods for the establishment of the NCI series of lung cancer cell lines. Journal of Cellular Biochemistry, 63(S24), 24-31.
[10] Goumas, F.A., et al., Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. International Journal of Cancer, 2015. 137(5): p. 1035-1046.
[11] Gerlier, D., & Thomasset, N. (1986). Use of MTT colorimetric assay to measure cell activation. Journal of immunological methods, 94(1-2), 57-63.
[12] Kalkavan, H., Chen, M. J., Crawford, J. C., Quarato, G., Fitzgerald, P., Tait, S. W., ... & Green, D. R. (2022). Sublethal cytochrome c release generates drug-tolerant persister cells. Cell, 185(18), 3356-3374.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
